Postoperative radiotherapy in the treatment of male breast carcinoma: A single institute experience

Journal of the National Medical Association

Volumn 98, Issue 4, 2006, Pages 559-563

  Atahan, Lale ^a,b   Yildiz, Ferah ^a,b   Selek, Ugur ^a,b   Sari, Sait ^a,b   Gurkaynak, Murat ^a,b  

^a Hacettepe University ^*

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Men's health; Radiotherapy

Indexed keywords

DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MALE; MALE BREAST; MASTECTOMY; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ACTUARIAL ANALYSIS; ADULT; AGED; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; HUMANS; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 33645698962     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13-year review of 89 patients. J Clin Oncol. 1984;2:903-909.
2. Ciatto S, Olossa A, Bonardi R, et al. Male Breast Cancer: Review of a multicenter series of 150 patients. Tumori. 1990;76:555-558,
3. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-57.
4. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53:447-457.
6. Cox DR. Regression methods and life tables. Journal of the Royal Statistical Society. 1972;34:187-220,
7. Overgaard M, Christensen JJ, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990;19(5):1121-1124.
8. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337(14):949-955.
9. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337(14):956-962.
10. Crichlow RW. Carcinoma of the male breast. Surg Gynecol Obstet. 1972;134:1011-1019.
11. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629-639.
12. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;137:678-687.
13. Stierer M, Rosen H, Weitensfelder W, et al. Male breast cancer: Austrian experience. World J Surg 1995;19:687-692; discussion 692-683.
14. Scott-Conner CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775-780; discussion 780-771.
15. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538-549.
16. Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734-748.
17. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24:548-552.
18. Rosenblatt KA, Thomas DB, McTiernan A, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst. 1991;83:849-854.
19. Sverdlov RS, Barshack I, Bar Sade RB, et al. Genetic analyses of male breast cancer in Israel. Genet Test. 2000;4:313-317.
20. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet. 1995;57:1-7.
21. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676-689.
22. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480-1490.
23. Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4:R2.
24. Ottini L, Masala G, D'Amico C, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res. 2003;63:342-347.
25. Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143-151.
26. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet Oncol. 1998;352:930-942.
27. Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol. 1987;10:55-60.
28. Patel HZn, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer. 1989;64:1583-1585.
29. Izquierdo MA, Alonso C, De Andres L et al. Male breast cancer. Report of a series of 50 cases. Acta Oncol. 1994;33:767-771.
30. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83:498-509.
31. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31 A:1960-1964.
32. Spence RA, MacKenzie G, Anderson JR, et al. Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases. Cancer. 1985;55:648-652.
33. Guinee VF, Olsson H, Moller T, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer. 1993;71:154-161.
34. Perkins GH, Middleton LP, Garcia SM, et al. Male breast carcinoma: outcomes and predictors of local-regional failure in patients treated without radiation therapy. Breast Cancer Res Treat. 2002;76:5121.
35. Levine MN, Bramwell VH, Pritchard KI, et al. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1998;16(8):2651-2658.
36. Dong C, Hemminki K. Second primary breast cancer in men. Breast Cancer Res Treat. 2001;66:171-172.
37. Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94:1330-1332.